Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9832377rdf:typepubmed:Citationlld:pubmed
pubmed-article:9832377lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0042036lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0033148lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0185115lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:9832377lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:9832377pubmed:issue1lld:pubmed
pubmed-article:9832377pubmed:dateCreated1999-2-8lld:pubmed
pubmed-article:9832377pubmed:abstractTextA new high-performance liquid chromatographic method for simultaneous determination of primidone (PRM) and of its three major metabolites, phenobarbital (PB), p-hydroxyphenobarbital (p-HO-PB) and phenylethylmalonamide (PEMA), in rat urine, was developed. After acid hydrolysis, these compounds were extracted from urine by means of a Bond Elut Certify LRC column with good clean-up. The extracts were chromatographed on a C18 reversed-phase column using isocratic elution at 40 degrees C, with UV detection at 227 nm. The limit of detection was 0.5 mg/ml for the four compounds. Good linearity (r2>0.99) was observed within the calibration ranges studied: 37.4-299.3 microg/ml for PRM, 26.4-211.2 microg/ml for PB, 12.5-100.2 microg/ml for p-HO-PB and 12.1-97.0 microg/ml for PEMA. Repeatability was in the range 3.1-6.8%. This method constitutes a useful tool for studies on the influence of various parameters on primidone metabolism.lld:pubmed
pubmed-article:9832377pubmed:languageenglld:pubmed
pubmed-article:9832377pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:citationSubsetIMlld:pubmed
pubmed-article:9832377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9832377pubmed:statusMEDLINElld:pubmed
pubmed-article:9832377pubmed:monthOctlld:pubmed
pubmed-article:9832377pubmed:issn1387-2273lld:pubmed
pubmed-article:9832377pubmed:authorpubmed-author:LafontOOlld:pubmed
pubmed-article:9832377pubmed:authorpubmed-author:ChabenatCClld:pubmed
pubmed-article:9832377pubmed:authorpubmed-author:MénagerSSlld:pubmed
pubmed-article:9832377pubmed:authorpubmed-author:FerrantiVVlld:pubmed
pubmed-article:9832377pubmed:issnTypePrintlld:pubmed
pubmed-article:9832377pubmed:day23lld:pubmed
pubmed-article:9832377pubmed:volume718lld:pubmed
pubmed-article:9832377pubmed:ownerNLMlld:pubmed
pubmed-article:9832377pubmed:authorsCompleteYlld:pubmed
pubmed-article:9832377pubmed:pagination199-204lld:pubmed
pubmed-article:9832377pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:meshHeadingpubmed-meshheading:9832377-...lld:pubmed
pubmed-article:9832377pubmed:year1998lld:pubmed
pubmed-article:9832377pubmed:articleTitleSimultaneous determination of primidone and its three major metabolites in rat urine by high-performance liquid chromatography using solid-phase extraction.lld:pubmed
pubmed-article:9832377pubmed:affiliationLaboratoire de Pharmacochimie, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne-du-Rouvray, France.lld:pubmed
pubmed-article:9832377pubmed:publicationTypeJournal Articlelld:pubmed